R C F (RCF)

FairStock Score: 61/100 — STEADY

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Free cash flow of ₹1,683 Cr is strong and provides a cushion for dividends and debt.
• Debt/equity of 0.58 is moderate; Altman Z-score 2.49 and Piotroski F-score 7/9 indicate decent financial health.
• Promoter holding of 75% provides stability and aligned long-term ownership.
• Book value of ₹86.01 and positive net profit offer some downside support in an asset-heavy fertilizer business.

Concerns

• ROE of 6.60% and ROCE of 7.49% are weak; returns on capital are below what a great business should produce.
• Sales growth is negative at -2.66% and the latest quarter net margin is thin: ₹81 Cr profit on ₹4,236 Cr sales.
• Valuation is rich: P/E 22.53, P/B 1.52, and price ₹130.43 is about 20.9% above Graham Number ₹104.85.
• EV/EBITDA of 165.74 is extremely high, suggesting earnings are low relative to the enterprise value.

AI Analysis

When I look at R C F, I first ask whether the business economics justify a purchase. The latest quarter shows sales of ₹4,236 crore and net profit of just ₹81 crore—a thin margin of under 2%. Over the year, sales fell 2.66%, while reported profit rose 18.08%. I'm wary when profit growth runs far ahead of sales; it often reflects cost cuts or base effects, not durable demand. The balance sheet is acceptable: debt/equity of 0.58, free cash flow of ₹1,683 crore, and a Piotroski score of 7/9. The Altman Z-score of 2.49 suggests no near-term distress. Promoter holding at 75% is stable. However, the returns on capital are weak. ROE is just 6.60%, and ROCE is 7.49%—not enough to make me believe this business has a wide moat. Book value is ₹86.01, but the stock trades at ₹130.43, or 1.52 times book. With a P/E of 22.53, declining sales, and a dividend yield of only 1.04%, the market is asking a rich price for a commodity-like business. Graham's formula gives a value of ₹104.85; at today's price, my margin of safety is negative, about -20.92%. A DCF of ₹302.65 is tempting, but I can't ignore an EV/EBITDA of 165.74—the earnings base is too thin relative to enterprise value. I also notice the 52-week range is ₹106.00 to ₹164.49, so the current price is neither a deep distress level nor a clear bargain. A good rule is: a fair price on a mediocre business is still a poor investment. R C F looks like a steady cyclical player, not a compounder. For an Indian retail investor, this stock belongs on the watchlist, not in the portfolio—unless the price falls well below book value or returns on capital improve substantially.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer